Clinical trials
Recruiting Recurrence trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Daiichi Sankyo | 2 |
| Regeneron Pharmaceuticals | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| AbbVie | 1 |
| Chang Gung Memorial Hospital | 1 |
| Chung Shan Medical University | 1 |
| DualityBio Inc. | 1 |
| E-DA Hospital | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 19 |
| Multiple Myeloma | 4 |
| Biliary Tract Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Lung Neoplasms | 2 |
| Lymphoma, B-Cell | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Non-Hodgkin | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.